비만과 이상지질혈증을 동반한 비알코올 지방간질환 환자 치험 1례
A Case Report of Nonalcoholic Fatty Liver Disease with Obesity and Dyslipidemia
0
조회
0
다운로드
3
인용
0
참고문헌
키워드
초록
Objectives: This study aims to report the clinical efficacy of Korean medical treatment of a patient with nonalcoholic fatty liver disease accompanied by obesity and dyslipidemia. Methods: A 52-year-old man with nonalcoholic fatty liver disease, obesity, and dyslipidemia was treated with Saenggangunbi-tang extract from November 3, 2021 to January 8, 2022. During the treatment period, the patient also undertook exercise and maintained a hypocaloric diet to reduce body weight. Changes were observed in the patient’s symptoms, laboratory findings, such as liver enzymes and lipid profiles, and bioelectrical impedance analyzer results. Results: After taking Saenggangunbi-tang extract for approximately two months, with concomitant adjustments to exercise and diet, the serum levels of liver enzymes and triglyceride were decreased and the patient’s body weight, body mass index, hepatic steatosis index, and visceral fat area were also reduced. In addition, symptoms including fatigue and dyspepsia improved. Conclusion: This study suggests that Saenggangunbi-tang extract with exercise and a regulated diet could be a helpful treatment strategy for managing nonalcoholic fatty liver disease with metabolic disorders.
Abstract
Objectives: This study aims to report the clinical efficacy of Korean medical treatment of a patient with nonalcoholic fatty liver disease accompanied by obesity and dyslipidemia. Methods: A 52-year-old man with nonalcoholic fatty liver disease, obesity, and dyslipidemia was treated with Saenggangunbi-tang extract from November 3, 2021 to January 8, 2022. During the treatment period, the patient also undertook exercise and maintained a hypocaloric diet to reduce body weight. Changes were observed in the patient’s symptoms, laboratory findings, such as liver enzymes and lipid profiles, and bioelectrical impedance analyzer results. Results: After taking Saenggangunbi-tang extract for approximately two months, with concomitant adjustments to exercise and diet, the serum levels of liver enzymes and triglyceride were decreased and the patient’s body weight, body mass index, hepatic steatosis index, and visceral fat area were also reduced. In addition, symptoms including fatigue and dyspepsia improved. Conclusion: This study suggests that Saenggangunbi-tang extract with exercise and a regulated diet could be a helpful treatment strategy for managing nonalcoholic fatty liver disease with metabolic disorders.
참고문헌 (20)
- 윤승규, "지방간의 진단과 치료", 대한내과학회지, 76(6), pp.677~679 (2009), 대한내과학회
- Chalasani N, "The diagnosis and management of nonalcoholic fatty liver disease : Practice guidance from the American association for the study of liver diseases", Hepatology, 67(1), pp.328~357 (2018)
- Diehl AM, "Cause, pathogenesis, and treatment of nonalcoholic steatohepatitis", N Engl J Med, 377(21), pp.2063~2072 (2017)
- 강성희, "KASL clinical practice guidelines: Management of nonalcoholic fatty liver disease", Clinical and Molecular Hepatology, 27(3), pp.363~401 (2021), 대한간학회
- Sheka AC, "Nonalcoholic Steatohepatitis : A Review", JAMA, 323(12), pp.1175~1183 (2020)
- Jarvis H, "Metabolic risk factors and incident advanced liver disease in non-alcoholic fatty liver disease(NAFLD) : A systematic review and meta-analysis of population-based observational studies", PLoS Med, 17(4), pp.e1003100~ (2020)
- Fabbrini E, "Obesity and nonalcoholic fatty liver disease : Biochemical, metabolic, and clinical implications", Hepatology, 51(2), pp.679~689 (2010)
- Katsiki N, "Non-alcoholic fatty liver disease and dyslipidemia : An update", Metabolism, 65(8), pp.1109~1123 (2016)
- Lee JH, "Hepatic steatosis index : a simple screening tool reflecting nonalcoholic fatty liver disease", Dig Liver Dis, 42(7), pp.503~508 (2010)
- Angulo P, "Non-alcoholic fatty liver disease", J Gastroenterol Hepatol, 17(Suppl), pp.S186~S190 (2002)
- Younossi ZM, "Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes", Hepatology, 64(1), pp.73~84 (2016)
- Polyzos SA, "Obesity and nonalcoholic fatty liver disease : From pathophysiology to therapeutics", Metabolism, 92, pp.82~97 (2019)
- Milić S, "Non-alcoholic fatty liver disease and obesity : biochemical, metabolic and clinical presentations", World J Gastroenterol, 20(28), pp.9330~9337 (2014)
- Reginato E, "Effect of short term intensive lifestyle intervention on hepatic steatosis indexes in adults with obesity and", or type 2 diabetes, 2019, pp.8(6), 851~
- Sorrentino G, "Efficacy of lifestyle changes in subjects with non-alcoholic liver steatosis and metabolic syndrome may be improved with an antioxidant nutraceutical : a controlled clinical study", Drugs R D, 15(1), pp.21~25 (2015)
- Woo HJ, "Oriental Internal Medicine on Hepatobiliary System, Hematology and Toxicology", pp.307~315 (2016), Nado
- Kim BW, "Clinical analysis and the effect of Saenggangunbitang on 3, 136 cases of the chronicle hepatitis patients", The Journal of Korean Oriental Medicine, 14(1), pp.216~223 (1993)
- 김하연, "대사증후군을 동반한 비알코올성 지방간염 치험 1례", 대한한방내과학회지, 38(2), pp.125~130 (2017), 대한한방내과학회
- Yang HJ, "A clinical study of 5 cases of patients who have nonalcoholic fatty liver disease(NAFLD)treated by Saenggangeonbi-tang", J Int Korean Med, pp.141~151 (2011)
- Choi ES, "A case report of adolescent nonalcoholic fatty liver disease(NAFLD)with severe obesity", J Int Korean Med, pp.89~95 (2015)